(Q84782013)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728437%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Rapid detection of JAK2 V617F mutation using high-resolution melting analysis with LightScanner platform (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728437%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Jun Qian

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728437%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jiang Lin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728437%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Dong-Ming Yao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728437%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Qin Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728437%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Gao-Fei Xiao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728437%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Run-Bi Ji

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728437%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Yun Li

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728437%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jing Yang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728437%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Zhen Qian

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728437%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20728437

20 June 2024

publication date

19 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728437%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

11 February 2020

https://api.elsevier.com/content/article/PII:S0009898110005176?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

https://api.elsevier.com/content/article/PII:S0009898110005176?httpAccept=text/plain

20 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

20 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728437%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

411

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728437%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

23-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728437%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

2097-2100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728437%20AND%20SRC:MED&resulttype=core&format=json

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

11 February 2020

cites work

2

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

A unique activating mutation in JAK2 (V617F) is at the origin of polycythemia vera and allows a new classification of myeloproliferative diseases

20 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

Identification of an acquired JAK2 mutation in polycythemia vera

20 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

20 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

A gain-of-function mutation of JAK2 in myeloproliferative disorders

20 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

20 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis.

20 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

20 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera

20 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology

20 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

High-resolution genotyping by amplicon melting analysis using LCGreen

20 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

Amplicon DNA melting analysis for mutation scanning and genotyping: cross-platform comparison of instruments and dyes

20 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

High-resolution melt curve analysis: initial screening for mutations in BCR-ABL kinase domain

20 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

Diagnostic guidelines for high-resolution melting curve (HRM) analysis: an interlaboratory validation of BRCA1 mutation scanning using the 96-well LightScanner

20 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

Detection of the JAK2 V617F mutation by LightCycler PCR and probe dissociation analysis

20 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

Detection of the JAK2V617F mutation by asymmetric PCR and melt curve analysis

20 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms

20 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

Detection of the JAK2 V617F missense mutation by high resolution melting analysis and its validation.

20 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

Interlaboratory development and validation of a HRM method applied to the detection of JAK2 exon 12 mutations in polycythemia vera patients

20 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis.

20 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

Unlabeled oligonucleotides as internal temperature controls for genotyping by amplicon melting

20 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

Comparative evaluation of three JAK2V617F mutation detection methods

20 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

A simple, rapid, and sensitive method for the detection of the JAK2 V617F mutation.

20 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia

20 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

A quantitative assay for JAK2(V617F) mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis.

20 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

Identification of the JAK2 V617F mutation in chronic myeloproliferative disorders using FRET probes and melting curve analysis

20 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

A sensitive and reliable semi-quantitative real-time PCR assay to detect JAK2 V617F in blood.

20 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis.

20 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

Design and evaluation of a real-time PCR assay for quantification of JAK2 V617F and wild-type JAK2 transcript levels in the clinical laboratory

20 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CCA.2010.08.020

20 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728437%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference